scp776

N/A

Report date: 2022/10/21 20:01:22

Base Information

Drug Namescp776
Drug Alias Namescp776
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsIschemic Stroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSilver Creek Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSilver Creek Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsIschemic Stroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A